Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ACADIA HEALTHCARE COMPANY, INC.

(ACHC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Correction: Mizuho Securities Maintains Price Target for Acadia Healthcare Company at $62, Reiterates Neutral Rating

06/07/2021 | 04:25pm EDT


© MT Newswires 2021
All news about ACADIA HEALTHCARE COMPANY, INC.
07/12Acadia Healthcare Announces Date for Second Quarter 2021 Earnings Release
GL
07/09ACADIA HEALTHCARE : Seaport Global Initiates Coverage on Acadia Healthcare With ..
MT
06/30ACADIA HEALTHCARE : Bronson Healthcare Partners With Acadia Healthcare to Build ..
BU
06/30ACADIA HEALTHCARE : Forms Joint Venture with Bronson Health to Build a New Behav..
BU
06/30Acadia Healthcare Company, Inc. Forms Joint Venture with Bronson Health to Bu..
CI
06/17ACADIA HEALTHCARE : Insiders Make Significant Stock Sales in Acadia Healthcare (..
MT
06/16INSIDER TRENDS : Insider Prolongs Selling Trend at Acadia Healthcare
MT
06/16INSIDER TRENDS : Insider Disposition Eases Back 90-Day Buy Trend at Acadia Healt..
MT
06/15Inpatient Admissions, Outpatient Visits Log Annual Growth For Third Straight ..
MT
06/15BofA Securities Raises Price Objectives for Healthcare Facilities as Elective..
MT
More news
Financials (USD)
Sales 2021 2 271 M - -
Net income 2021 193 M - -
Net Debt 2021 1 325 M - -
P/E ratio 2021 28,8x
Yield 2021 -
Capitalization 5 539 M 5 539 M -
EV / Sales 2021 3,02x
EV / Sales 2022 2,81x
Nbr of Employees 35 400
Free-Float 98,7%
Chart ACADIA HEALTHCARE COMPANY, INC.
Duration : Period :
Acadia Healthcare Company, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ACADIA HEALTHCARE COMPANY, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Last Close Price 61,72 $
Average target price 68,60 $
Spread / Average Target 11,1%
EPS Revisions
Managers and Directors
Debra Kay Osteen Chief Executive Officer & Director
David M. Duckworth Chief Financial Officer
Reeve Byron Waud Chairman
Michael V. Genovese Chief Medical Officer
John S. Hollinsworth Executive Vice President-Operations